1Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence Of major bansfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA. 2000;284:229-235.
2Ung AE, Rodbins KE, Brown TM, et al. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infections, window period. JAMA. 2000;284:210-214.
3Busch M, Chamberland M, Epstein J, et al. Oversight and monitoring of blood safety in the United States. Vox Sarrg 1999;77:67-76.
4Schreiber G8, Busch MP, Kleirman SH, Korelitz 1J. The risk of transfusion -transmitted viral infections N Engl J Med. 1996;334:1685-1690.
5Centers for Disease Control and Prevention (CDC). Table 5: AIDS cases by age group, exposure category, and sex. HIVIAIDS Sutveill Rep. 1999;11(1):12
6Centers for Disease Control and Prevention (CDC). Recommendations for pevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb J Mortat Wkly Rep. 1998;47(RR-19):1-39.
7Imagawa DT. Lee MH, Wolinsky SM, et al. Human immunodeficiency virus type 1 infection in hornosexual men who remain seronegative for prolonged periods.N Engl J Med. 1989;320:1458-1462.
8Allain J. Genomic screening for blood-borne viruses in transfusion settings. Clin Lab Haematol. 2000;22:1-10.
9Roth WK, Weber M. Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus and HIV- 1 in a blood-bank setting. Lancet. 1999;.353;359-363.
10Aubuchon JP, Birkmeyer JD. Busch MP. Cost-effectiveness of expanded HIV test orotocols for donated blood. Transfusion. 1997;37:45-51.
